FTC Seeks to Block Sanofi’s Acquisition of Rare Disease Drug that Threatens
FTC Seeks to Block Sanofi's Acquisition of Rare Disease Drug that Threatens Sanofi's Monopoly Federal Trade Commission NewsPress Release: Statement on FTC challenge to proposed license agreement with Maze Therapeutics…